Genetic modifiers of the insulin resistance phenotype in mice

Diabetes

Volumn 49, Issue 4, 2000, Pages 589-596

  Kido, Yoshiaki ^a,c   Philippe, Neubert ^a   Schäffer, Alejandro A ^b   Accili, Domenico ^a,c,d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Coll Phys Surgs of Columbia Univ ^*  (United States)

^d Berrie Research Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 2; CONTROLLED STUDY; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HETEROZYGOTE; HYPERINSULINEMIA; INSULIN RESISTANCE; KNOCKOUT MOUSE; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RECEPTOR GENE;

EID: 0034079629     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.4.589     Document Type: Article

References (52)

1. Ghosh S, Schork NJ: Genetic analysis of NIDDM: the study of quantitative traits. Diabetes 45:1-14, 1996
2. Kahn CR, Vicent D, Doria A: Genetics of non-insulin-dependent (type-II) diabetes mellitus. Annu Rev Med 47:509-531, 1996
3. Todd JA: Transcribing diabetes. Nature 384:407-408, 1996
4. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 265: 2037-2048, 1994
5. Imai Y, Philippe N, Sesti G, Accili D, Taylor SI: Expression of variant forms of insulin receptor substrate-1 identified in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 82:4201-4207, 1997
6. Almind K, Inoue G, Pedersen O, Kahn CR: A common amino acid polymorphism in insulin receptor substrates-1 causes impaired insulin signaling. J Clin Invest 97:2569-2575, 1996
7. Accili D, Suzuki Y: Gene targeting by homologous recombination in mouse embryonic stem cells. In Molecular Endocrinology: Basic Concepts and Clinical Correlations. Weintraub BD, Ed. New York, Raven Press, 1994, p. 95-104
8. Dietrich WF, Copeland NG, Gilbert DJ, Miller JC, Jenkins NA, Lander ES: Mapping the mouse genome: current status and future prospects. Proc Natl Acad Sci U S A 92:10849-10853, 1995
9. Leiter E, Herberg L: The polygenetics of diabesity in mice. Diabetes Rev 5:131-148, 1997
10. Bruning JC, Winnay J, Bonner WS, Taylor SI, Accili D, Kahn CR: Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-572, 1997
11. Terauchi Y, Iwamoto K, Tamemoto H, Komeda K, Ishii C, Kanazawa Y, Asanuma N, Aizawa T, Akanuma Y, Yasuda K, Kodama T, Tobe K, Yazaki Y, Kadowaki T: Development of non-insulin-dependent diabetes mellitus in the double knockout mice with disruption of insulin receptor substrate-1 and beta cell glucokinase genes: genetic reconstitution of diabetes as a polygenic disease. J Clin Invest 99:861-866, 1997
12. Chung WK, Belfi K, Chua M, Wiley J, Mackintosh R, Nicolson M, Boozer CN, Liebel RL: Heterozygosity for Lep(ob) or Lep(rdb) affects body composition and leptin homeostasis in adult mice. Am J Physiol 274:R985-R990, 1998
13. Frankel WN, Schork NJ: Who's afraid of epistasis? Nat Genet 14:371-373, 1996
14. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H: Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106-109, 1996
15. Simpson EM, Linder CC, Sargent EE, Davisson MT, Mobraaten LE, Sharp JJ: Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet 16:19-27, 1997
16. Lincoln S, Daly M, Lander ES: Mapping genes controlling quantitative traits with MAPMAKER/QTL 1.1. Whitehead Institute Technical Report, 1992
17. Paterson AH, Lander ES, Hewitt JD, Peterson S, Lincoln SE, Tanksley SD: Resolution of quantitative traits into Mendelian factors by using a complete linkage map of restriction fragment length polymorphisms. Nature 335:721-726, 1988
18. Lander ES, Green P: Construction of multilocus genetic linkage maps in humans. Proc Natl Acad Sci U S A 84:2363-2367, 1987
19. Groot PC, Moen CJ, Dietrich W, Stoye JP, Lander ES, Demant P: The recombinant congenic strains for analysis of multigenic traits: genetic composition. FASEB J 6:2826-2835, 1992
20. Gould KA, Dietrich WF, Borenstein N, Lander ES, Dove WF: Mom 1 is a semi-dominant modifier of intestinal adenoma size and multiplicity in Min/+ mice. Genetics 144:1769-1776, 1996
21. Lander E, Kruglyak L: Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247, 1995
22. Bogardus C: Metabolic abnormalities in the development of non-insulin-dependent diabetes mellitus. In Diabetes Mellitus: A Fundamental and Clinical Text. LeRoith D, Taylor SI, Olefsky GM, Eds. Philadelphia, Lippincott-Raven, 1996, p. 459-467
23. Ranheim T, Dumke C, Schueler KL, Cartee GD, Attie AD: Interaction between BTBR and B6 genomes produces an insulin resistance syndrome in (BTBR × B6) F1 mice. Arterioscler Thromb Vasc Biol 17:3286-3293, 1997
24. Leiter E, Herberg L: Genetic analysis of polygenic NIDDM in mice (Abstract). Diabetes 45:100A, 1996
25. Leiter EH, Reifsnyder PC, Flurkey K, Partke HJ, Junger E, Herberg L: NIDDM genes in mice: deleterious synergism by both parental genomes contributes to diabetogenic thresholds. Diabetes 47:1287-1295, 1998
26. Sibilia M, Wagner E: Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269:234-238, 1995
27. Threadgill DW, Dlugosz AA, Hansen LA, Tennenbaum T, Lichti U, Yee D, LaMantia C, Mourton T, Herrup K, Harris RC, Barnard JA, Yuspa SH, Coffey RJ, Magnuson T: Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269:230-234, 1995
28. Bonyadi M, Rusholme SAB, Cousins FM, Su HC, Biron CA, Farrall M, Akhurst RJ: Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knock-out mice. Nat Genet 15:207-211, 1997
29. Fu associated with variability in insulin production and susceptibility to NIDDM. Genomics 41:332-344, 1997
30. Coleman DL: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 14:141-148, 1978
31. Dietrich WF, Lander ES, Smith JS, Moser AR, Gould KA, Luongo C, Borenstein N, Dove W: Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75:631-639, 1993
32. Gould KA, Luongo C, Moser AR, McNeley MK, Borenstein N, Shedlovsky A, Dove WF, Hong K, Dietrich WF, Lander ES: Genetic evaluation of candidate genes for the Mom 1 modifier of intestinal neoplasia in mice. Genetics 144:1777-1785, 1996
33. Nagle DL, McGrail SH, Vitale J, Woolf EA, Dussault BJ Jr, DiRocco L, Holmgren L, Montagno J, Bork P, Huszar D, Fairchild-Huntress V, Ge P, Keilty J, Ebeling C, Baldini L, Gilchrist J, Burn P, Carlson GA, Moore KJ: The mahogany protein is a receptor involved in suppression of obesity. Nature 398:148-152, 1999
34. Gunn TM, Miller KA, He L, Hyman RW, Davis RW, Azarani A, Schlossmann SF, Duke-Cohan JS, Barsh GS: The mouse mahogany locus encodes a transmembrane form of human attractin. Nature 398:152-156, 1999
35. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM, Trembling PM, Mann CJ, Shoulders CC, Graf D, St. Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J: Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21:76-83, 1999
36. Mohlke KL, Purkayastha AA, Westrick RJ, Smith PL, Petryniak B, Lowe JB, Ginsburg D: Mvwf, a dominant modifier of murine von Willebrand factor, results from altered lineage-specific expression of a glycosyltransferase. Cell 96:111-120, 1999
37. Risch N, Ghosh S, Todd JA: Statistical evaluation of multiple-locus linkage data in experimental species and its relevance to human studies: application to nonobese diabetic (NOD) mouse and human insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 53:702-714, 1993
38. van Wezel T, Stassen AP, Moen CJ, Hart AA, van der Valk MA, Demant P: Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat Genet 14:468-470, 1996
39. Fijneman RJ, de Vries SS, Jansen RC, Demant P: Complex interactions of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat Genet 14:465-467, 1996
40. Gu L, Johnson M, Lusis A: Quantitative trait locus analysis of plasma lipoprotein levels in an autoimmune disease, and atherogenesis. Arterioscler Thromb Vasc Biol 19:442-453, 1999
41. Ewart-Toland A, Mounzih K, Qiu J, Chehab F: Effect of the genetic background on the reproduction of leptin-deficient obese mice. Endocrinology 140:732-738, 1999
42. Rapp JP, Garrett MR, Deng AY: Construction of a double congenic strain to prove an epistatic interaction on blood pressure between rat chromosomes 2 and 10. J Clin Invest 101:1591-1595, 1998
43. Cahill GF Jr, Jones EE, Lauris V, Steinke J, Soeldner JS: Studies on experimental diabetes in the Wellesley hybrid mouse. II. Serum insulin levels and response of peripheral tissues. Diabetologia 3:171-174, 1967
44. Jeffrey IJ, Gordon C, Yates AP, Fox H: Obesity, hyperinsulinaemia and hyperplasia of the pancreatic islets in ageing (C3H/HeJ × B6) F1 hybrid mice. Horm Metab Res 18:210-212, 1986
45. Leiter EH, Chapman HD, Coleman DL: The influence of genetic background on the expression of mutations at the diabetes locus in the mouse. V. Interaction between the db gene and hepatic sex steroid sulfotransferases correlates with gender-dependent susceptibility to hyperglycemia. Endocrinology 124:912-922, 1989
46. York B, Lei K, West DB: Sensitivity to dietary obesity linked to a locus on chromosome 15 in a CAST/Ei × B6 F2 intercross. Mamm Genome 7:677-681, 1996
47. West DB, Goudey-Lofevre J, York B, Truett GE: Dietary obesity linked to genetic loci on chromosomes 9 and 15 in a polygenic mouse model. J Clin Invest 94:1410-1416, 1994
48. Gauguier D, Froguel P, Parent V, Bernard C, Bihoreau MT, Portha B, James MR, Penicaud L, Lathrop M, Ktorza A: Chromosomal mapping of genetic loci associated with non-insulin dependent diabetes in the GK rat. Nat Genet 12:38-43, 1996
49. Galli J, Li LS, Glaser A, Ostenson CG, Jiao H, Fakhrai-Rad H, Jacob HJ, Lander ES, Luthman H: Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet 12:31-37, 1996
50. Hirayama I, Yi Z, Izumi S, Arai I, Suzuki W, Nagamachi Y, Kuwano H, Takeuchi T, Izumi T: Genetic analysis of obese diabetes in the TSOD mouse. Diabetes 48:1183-1191, 1999
51. Ogg S, Ruvkun G: The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway. Mol Cell 2:887-893, 1998
52. Maehama T, Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378, 1998